FDA Investigator: Kimberly L. Schultz
- Kimberly L. Schultz first started conducting FDA inspections in 2019, with the last inspection in 2023. Over that time, Kimberly L. Schultz has conducted 4 inspections at 4 companies across 4 sites.
Get Kimberly Schultz's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Carsgen Therapeutics, Durham | December 2023
Available Now - $199
Kimberly L. Schultz
Biologics Form 483
FDA 483 Juno Therapeutics, Bothell | October 2020
Available Now - $199
Kimberly L. Schultz
Biologic Form 483
FDA 483 Novartis Pharmaceuticals, Morris Plains | Aug 2019
Available Now - $199
Kimberly L. Schultz
Biologic Form 483
FDA 483 Celgene a Bristol Myers Squibb Company, Summit | 2021
Out-of-stock
Kimberly L. Schultz
Biologic Form 483
Co-Investigators (12)
- Travis S. Bradley, FDA Investigator
- Nirjal Bhattarai, FDA Investigator
- Latorie S. Jones, FDA Investigator
- Nimmy Mathews, FDA Investigator
- Linda Thai, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Eileen A. Liu, FDA Investigator
- David E. Bailey, FDA Investigator
- Rabia Ballica, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Susan M. Jackson, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator